EXPLORE THE SCIENCE

cost-effectiveness

DepressionJune 29, 2026

PReDicT Antidepressant Algorithm Had Uncertain Cost-Effectiveness

TL;DR: A 2026 study in BJPsych Open found that closely monitored antidepressant care improved quality of life and reduced societal costs in both PReDicT and usual-care groups, while the PReDicT algorithm added uncertain, country-dependent economic value. Key F…

Read article

AntidepressantsMay 6, 2026

Esketamine Was Not “Cost-Effective” for Treatment-Resistant Depression in Hong Kong

Esketamine Lost the Cost-Effectiveness Race in Hong Kong TL;DR: A 5-year Hong Kong model found esketamine plus an antidepressant bought only a small quality-adjusted survival gain at US$29,061 per patient, leaving it behind cheaper third-line options like comb…

Read article

PReDicT Antidepressant Algorithm Had Uncertain Cost-Effectiveness

Esketamine Was Not “Cost-Effective” for Treatment-Resistant Depression in Hong Kong

The findings. The context. The caveats.